倾向评分匹配-话题@MedSci - 梅斯（MedSci）

#倾向评分匹配#

8篇内容 | 870人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2085180, encodeId=d1bb20851803c, content=<a href='/topic/show?id=7c1a2e505d1' target=_blank style='color:#2F92EE;'>#倾向评分匹配#</a>, objectTitle=BMC Cancer：倾向评分匹配（PSM）研究表明抗PD-1联合索拉非尼较抗PD-1单药改善晚期肝细胞癌患者的预后, objectType=article, longId=294048, objectId=4fc429404878, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4fc429404878, replyNumber=0, likeNumber=65, createdTime=2022-07-10, rootId=0, userName=guojianrong, userId=d8f4110, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4fc429404878, moduleTitle=BMC Cancer：倾向评分匹配（PSM）研究表明抗PD-1联合索拉非尼较抗PD-1单药改善晚期肝细胞癌患者的预后, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=4fc429404878)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2085179, encodeId=223c20851e91b, content=<a href='/topic/show?id=7c1a2e505d1' target=_blank style='color:#2F92EE;'>#倾向评分匹配#</a>, objectTitle=Thorac Cancer：术后放疗可提高新辅助化疗+术后病理为ypN2的非小细胞肺癌患者的生存：来自SEER数据库倾向评分匹配分析, objectType=article, longId=291956, objectId=2f9f2919568c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2f9f2919568c, replyNumber=0, likeNumber=76, createdTime=2022-07-12, rootId=0, userName=guojianrong, userId=d8f4110, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2f9f2919568c, moduleTitle=Thorac Cancer：术后放疗可提高新辅助化疗+术后病理为ypN2的非小细胞肺癌患者的生存：来自SEER数据库倾向评分匹配分析, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=2f9f2919568c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2085177, encodeId=f39b20851e70b, content=<a href='/topic/show?id=7c1a2e505d1' target=_blank style='color:#2F92EE;'>#倾向评分匹配#</a>, objectTitle=Front Oncol：仑伐替尼（lenvatinib）对比索拉非尼（Sorafenib）治疗晚期肝细胞癌的疗效：倾向评分匹配（PSM）分析, objectType=article, longId=219316, objectId=14432193166f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=14432193166f, replyNumber=0, likeNumber=77, createdTime=2021-11-30, rootId=0, userName=guojianrong, userId=d8f4110, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=14432193166f, moduleTitle=Front Oncol：仑伐替尼（lenvatinib）对比索拉非尼（Sorafenib）治疗晚期肝细胞癌的疗效：倾向评分匹配（PSM）分析, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=14432193166f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2085178, encodeId=ec4220851e8fc, content=<a href='/topic/show?id=7c1a2e505d1' target=_blank style='color:#2F92EE;'>#倾向评分匹配#</a>, objectTitle=BMC Cancer：双药对比三药新辅助治疗局部进展期胃癌(LAGC)的疗效：倾向评分匹配(PSM)研究, objectType=article, longId=291845, objectId=199829184512, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=199829184512, replyNumber=0, likeNumber=62, createdTime=2022-10-14, rootId=0, userName=guojianrong, userId=d8f4110, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=199829184512, moduleTitle=BMC Cancer：双药对比三药新辅助治疗局部进展期胃癌(LAGC)的疗效：倾向评分匹配(PSM)研究, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=199829184512)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2085176, encodeId=0c2d20851e6b4, content=<a href='/topic/show?id=7c1a2e505d1' target=_blank style='color:#2F92EE;'>#倾向评分匹配#</a>, objectTitle=BMC Gastroenterology：倾向评分匹配分析口服乳果糖对复杂性阑尾炎患者的术后治疗效果的影响, objectType=article, longId=183397, objectId=3d2218339e76, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3d2218339e76, replyNumber=0, likeNumber=76, createdTime=2020-09-29, rootId=0, userName=guojianrong, userId=d8f4110, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3d2218339e76, moduleTitle=BMC Gastroenterology：倾向评分匹配分析口服乳果糖对复杂性阑尾炎患者的术后治疗效果的影响, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=3d2218339e76)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2085175, encodeId=8a7520851e563, content=<a href='/topic/show?id=7c1a2e505d1' target=_blank style='color:#2F92EE;'>#倾向评分匹配#</a>, objectTitle=倾向评分匹配的SPSS和R实现方法, objectType=article, longId=149731, objectId=e37e149e3181, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e37e149e3181, replyNumber=0, likeNumber=65, createdTime=2019-02-22, rootId=0, userName=guojianrong, userId=d8f4110, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e37e149e3181, moduleTitle=倾向评分匹配的SPSS和R实现方法, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=e37e149e3181)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2085173, encodeId=e2a020851e373, content=<a href='/topic/show?id=7c1a2e505d1' target=_blank style='color:#2F92EE;'>#倾向评分匹配#</a>, objectTitle=倾向评分匹配的SPSS、R和Stata实现方法, objectType=article, longId=72803, objectId=0f20e28038e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0f20e28038e, replyNumber=0, likeNumber=70, createdTime=2016-09-19, rootId=0, userName=guojianrong, userId=d8f4110, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0f20e28038e, moduleTitle=倾向评分匹配的SPSS、R和Stata实现方法, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=0f20e28038e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2085174, encodeId=689920851e43b, content=<a href='/topic/show?id=7c1a2e505d1' target=_blank style='color:#2F92EE;'>#倾向评分匹配#</a>, objectTitle=Cancer：倾向评分匹配分析尼洛替尼和达沙替尼治疗慢性期慢性粒细胞白血病, objectType=article, longId=76310, objectId=7223e63103e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7223e63103e, replyNumber=0, likeNumber=80, createdTime=2017-06-06, rootId=0, userName=guojianrong, userId=d8f4110, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7223e63103e, moduleTitle=Cancer：倾向评分匹配分析尼洛替尼和达沙替尼治疗慢性期慢性粒细胞白血病, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=7223e63103e)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

倾向评分匹配

2020-05-29

guojianrong (审核中...)

前往app查看评论内容

#倾向评分匹配#

BMC Cancer：倾向评分匹配（PSM）研究表明抗PD-1联合索拉非尼较抗PD-1单药改善晚期肝细胞癌患者的预后

2022-07-10

guojianrong (审核中...)

前往app查看评论内容

#倾向评分匹配#

Thorac Cancer：术后放疗可提高新辅助化疗+术后病理为ypN2的非小细胞肺癌患者的生存：来自SEER数据库倾向评分匹配分析

2022-07-12

guojianrong (审核中...)

前往app查看评论内容

#倾向评分匹配#

Front Oncol：仑伐替尼（lenvatinib）对比索拉非尼（Sorafenib）治疗晚期肝细胞癌的疗效：倾向评分匹配（PSM）分析

2021-11-30

guojianrong (审核中...)

前往app查看评论内容

#倾向评分匹配#

BMC Cancer：双药对比三药新辅助治疗局部进展期胃癌(LAGC)的疗效：倾向评分匹配(PSM)研究

2022-10-14

guojianrong (审核中...)

前往app查看评论内容

#倾向评分匹配#

BMC Gastroenterology：倾向评分匹配分析口服乳果糖对复杂性阑尾炎患者的术后治疗效果的影响

2020-09-29

guojianrong (审核中...)

前往app查看评论内容

#倾向评分匹配#

倾向评分匹配的SPSS和R实现方法

2019-02-22

guojianrong (审核中...)

前往app查看评论内容

#倾向评分匹配#

倾向评分匹配的SPSS、R和Stata实现方法

2016-09-19

guojianrong (审核中...)

前往app查看评论内容

#倾向评分匹配#

Cancer：倾向评分匹配分析尼洛替尼和达沙替尼治疗慢性期慢性粒细胞白血病

2017-06-06

科室
- - 订阅+
  - 更多科室
工具
服务